A lack of quality clinical data is hindering machine learning models for oncology and other treatments, says Steve Irvine, CEO of integrate.ai, who describes how federated learning approaches can enable secure access to a wider array of datasets.
Subscribe to:
Post Comments (Atom)
< + > CMS Reimbursement for Tech-Enabled Therapies with Joseph C. Sardano from Sensus Healthcare
We all know that one of the biggest challenges that the government faces is the speed at which technology is evolving. Whether it’s the FDA...
No comments:
Post a Comment